Skip to content
Back to NMTC

Neuroone Medical Technologies Corp

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
8
Purchases
2
Sales
6
Purchase value
$737.40K
Sale value
$54.85K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

David J. WambekeChief Business Officer
4
Filed Sep 8, 2026Period of report Aug 27, 20260001971798-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 27, 2026
Common StockF133,333$2.01$67.00K199,999Direct
Filing footnotes · 2
  1. F1The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. F225% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.
Open on SEC EDGAR
Mark ChristiansonMarket Development Director
4
Filed Jul 2, 2026Period of report Jun 30, 20260001709738-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 30, 2026
Common Stock10,000$3.1773$31.77K20,692Direct
Open on SEC EDGAR
Mark ChristiansonBusiness Development Director
4
Filed Apr 1, 2026Period of report Mar 30, 20260001709738-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 30, 2026
Common Stock15,363$0.74$11.37K198,920Direct
Open on SEC EDGAR
Mark ChristiansonBusiness Development Director
4
Filed Mar 16, 2026Period of report Mar 12, 20260001709738-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common Stock100$0.80$80.00214,283Direct
SaleMar 12, 2026
Common Stock817$0.80$653.60214,383Direct
Open on SEC EDGAR
Mark ChristiansonBusiness Development Director
4
Filed Mar 12, 2026Period of report Mar 10, 20260001709738-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 11, 2026
Common StockF22,109$0.80$1.69K215,200Direct
SaleMar 10, 2026
Common StockF111,611$0.80$9.29K217,309Direct
Filing footnotes · 2
  1. F1The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.8102 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. F2The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.805 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Open on SEC EDGAR
David J. WambekeChief Business Officer
4
Filed Mar 3, 2026Period of report Mar 1, 20260001971798-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 1, 2026
Common Stock1,000,000$0.6704$670.40K1,000,000Direct
Filing footnotes · 1
  1. F125% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.